Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Book a demo
Thrive Earlier Detection logo — Pioneering Life-Saving Cancer Detection with Advanced Liquid...

Thrive Earlier Detection

Pioneering Life-Saving Cancer Detection with Advanced Liquid Biopsy Solutions

Founded 2019 Series Unknown Total: $367.00M Biotechnology, Health Care

General Information

Company Name Thrive Earlier Detection
Founded Year 2019
Founders / Decision Makers
Team member
Industries Biotechnology, Health Care
Funding Stage Series Unknown
Social

Get notified when Thrive Earlier Detection moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About Thrive Earlier Detection

Thrive Earlier Detection is a healthcare company striving to revolutionize cancer detection through its advanced liquid biopsy solution, CancerSEEK. The company's dedication to integrating earlier cancer detection into routine medical care is reflected in its mission to save lives. Founded in 2019 by Third Rock Ventures, Thrive has garnered financial backing from prominent investors such as Section 32, Casdin Capital, Biomatics Capital, BlueCross BlueShield Venture Partners, The Invus Group, Camden Partners Nexus, Cowin Venture, Exact Sciences, and Gamma3. Thrive's groundbreaking liquid biopsy test, CancerSEEK, is designed to identify multiple cancers in their early stages and is set to form the foundation of the company's comprehensive cancer information platform. The recent Venture Round investment at 01 January 2023 from Curie.Bio reflects the continued support and belief in Thrive's pioneering approach to life-saving cancer detection.

Taxonomy: cancer detection, liquid biopsy, early cancer detection, biotech, investment, venture capital, medical innovation, health startup

Funding Rounds & Investors (3)

View All
Funding Stage Amount Investors Lead Investors Date
Venture Round •••••• 1
Investor
01 Jan 2023
Series B •••••• 9
Investor Investor Investor Investor Investor Investor Investor Investor
•••• •••• 		29 Jul 2020
Series A •••••• - 30 May 2019

Thrive Earlier Detection Alternatives & Competitors

Thrive Earlier Detection vs
BiPar Sciences
BiPar Sciences

Innovative therapies harnessing the power of PARP inhibitors to combat advanced cancers

Series C
Biotechnology, Health Care
Thrive Earlier Detection vs
Freenome
Freenome United States

Outpacing cancer starts with early detection

Unknown
403 employees
Biotechnology, Pharmaceutical
Thrive Earlier Detection vs
VCCC Alliance
VCCC Alliance Australia

Overcoming cancer together

73 employees

FAQ About Thrive Earlier Detection

Pioneering Life-Saving Cancer Detection with Advanced Liquid Biopsy Solutions
Thrive Earlier Detection was founded in 2019.
Thrive Earlier Detection operates in the following industries: Biotechnology, Health Care.
Thrive Earlier Detection has completed 3 funding rounds, raising a total of $367.00M. The latest funding stage is Series Unknown.
Top alternatives and competitors to Thrive Earlier Detection include BiPar Sciences, Freenome, VCCC Alliance, Amaroq Therapeutics, EpiGene. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Thrive Earlier Detection and BiPar Sciences are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors Thrive Earlier Detection and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

See how it works

One analytics cookie (Google Analytics). Cookie Policy